Answers are grounded in this paper and cite their sources.
Serologic reagents have played an important role in the diagnosis, treatment, and epidemiology of infectious diseases. A new technology has been developed for generating homogeneous antibodies that can be produced in large amounts and are available indefinitely. This technique promises to increase the reliability and sensitivity of immunoassays and may even provide antibodies that can be used safely in vivo.
No takes yet. Share an insight, caveat, or question.
Scharff et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: